Literature DB >> 31269274

Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus.

Richard H Lee1,2, Richard Sloane1,2, Carl Pieper1, Kenneth W Lyles1,2, Robert A Adler3,4, Courtney Van Houtven1,2, Joanne LaFleur5,6, Cathleen Colón-Emeric1,2.   

Abstract

Diabetes mellitus among older men has been associated with increased bone mineral density but paradoxically increased fracture risk. Given the interactions among medication treatment, glycemic control, and diabetes-associated comorbidities, the relative effects of each factor remains unclear. This retrospective study includes 652,901 male veterans aged ≥65 years with diabetes and baseline hemoglobin A1c (HbA1c) value. All subjects received primary care in the Veterans Health Administration (VHA) from 2000 to 2010. Administrative data included ICD9 diagnoses and pharmacy records and was linked to Medicare fee-for-service data. Hazard ratios (HR) for any clinical fracture and hip fracture were calculated using competing risk hazards models, adjusted for fracture risk factors including age, race/ethnicity, body mass index (BMI), alcohol and tobacco use, rheumatoid arthritis, corticosteroid use, as well as diabetes-related comorbidities including cardiovascular disease, chronic kidney disease, and peripheral neuropathy. HbA1c <6.5% was associated with a higher risk of any clinical fracture (HR = 1.08, 95% confidence interval [CI] 1.06-1.11) compared with the reference HbA1c of 7.5% to 8.5%. Fracture risk was not increased among those with A1c ≥8.5%, nor among those with A1c 6.5% to 7.5%. Use of insulin was independently associated with greater risk of fracture (HR = 1.10, 95% CI 1.07-1.12). There was a significant interaction between insulin use and HbA1c level, (p < 0.001), such that those using insulin with HbA1c <6.5% had HR = 1.23 and those with HbA1c 6.5% to 7.5% had HR = 1.15. Metformin use was associated with decreased fracture risk (HR = 0.88, 95% CI 0.87-0.90). We conclude that among older men with diabetes, those with HbA1c lower than 6.5% are at increased risk for any clinical and hip fracture. Insulin use is associated with higher fracture risk, especially among those with tight glycemic control. Our findings demonstrate the importance of the treatment regimen and avoiding hypoglycemia for fracture prevention in older men with diabetes.
© 2019 American Society for Bone and Mineral Research. © 2019 American Society for Bone and Mineral Research.

Entities:  

Keywords:  AGED; DIABETES MELLITUS; FRACTURE; MALE; RISK FACTORS

Year:  2019        PMID: 31269274      PMCID: PMC6854289          DOI: 10.1002/jbmr.3826

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  31 in total

1.  Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment.

Authors:  R Tamblyn; T Reid; N Mayo; P McLeod; M Churchill-Smith
Journal:  J Clin Epidemiol       Date:  2000-02       Impact factor: 6.437

2.  Older women with diabetes have an increased risk of fracture: a prospective study.

Authors:  A V Schwartz; D E Sellmeyer; K E Ensrud; J A Cauley; H K Tabor; P J Schreiner; S A Jamal; D M Black; S R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

3.  Fracture risk in diabetic elderly men: the MrOS study.

Authors:  Nicola Napoli; Elsa S Strotmeyer; Kristine E Ensrud; Deborah E Sellmeyer; Douglas C Bauer; Andrew R Hoffman; Thuy-Tien L Dam; Elizabeth Barrett-Connor; Lisa Palermo; Eric S Orwoll; Steven R Cummings; Dennis M Black; Ann V Schwartz
Journal:  Diabetologia       Date:  2014-06-09       Impact factor: 10.122

4.  Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Diabetologia       Date:  2005-05-21       Impact factor: 10.122

5.  Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture.

Authors:  Johanna H M Driessen; Hein A W van Onzenoort; Ronald M A Henry; Arief Lalmohamed; Joop P van den Bergh; Cees Neef; Hubert G M Leufkens; Frank de Vries
Journal:  Bone       Date:  2014-08-02       Impact factor: 4.398

Review 6.  Mechanisms of diabetes mellitus-induced bone fragility.

Authors:  Nicola Napoli; Manju Chandran; Dominique D Pierroz; Bo Abrahamsen; Ann V Schwartz; Serge L Ferrari
Journal:  Nat Rev Endocrinol       Date:  2016-09-23       Impact factor: 43.330

7.  Association between glycemic control and hip fracture.

Authors:  Troy H Puar; Joan J Khoo; Li W Cho; Ying Xu; Yuan T Chen; Adeline M Chuo; Cheng B Poh; Jen M Ng
Journal:  J Am Geriatr Soc       Date:  2012-08-02       Impact factor: 5.562

8.  Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.

Authors:  E Losada; B Soldevila; M S Ali; D Martínez-Laguna; X Nogués; M Puig-Domingo; A Díez-Pérez; D Mauricio; D Prieto-Alhambra
Journal:  Osteoporos Int       Date:  2018-06-02       Impact factor: 4.507

9.  Osteoporosis-related fracture case definitions for population-based administrative data.

Authors:  Lisa M Lix; Mahmoud Azimaee; Beliz Acan Osman; Patricia Caetano; Suzanne Morin; Colleen Metge; David Goltzman; Nancy Kreiger; Jerilynn Prior; William D Leslie
Journal:  BMC Public Health       Date:  2012-05-18       Impact factor: 3.295

10.  Associations with fracture in patients with diabetes: a nested case-control study.

Authors:  Jakob Starup-Linde; Søren Gregersen; Peter Vestergaard
Journal:  BMJ Open       Date:  2016-02-12       Impact factor: 2.692

View more
  12 in total

1.  Fracture risk in patients with type 2 diabetes aged ≥50 years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry.

Authors:  Alexander J Eckert; Julia K Mader; Marcus Altmeier; Steffen Mühldorfer; Anton Gillessen; Dhayana Dallmeier; Viral N Shah; Christoph Heyer; Bettina Hartmann; Reinhard W Holl
Journal:  J Diabetes Complications       Date:  2020-06-27       Impact factor: 2.852

2.  Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.

Authors:  Bowen Wang; Zehai Wang; Atharva A Poundarik; Mohammed J Zaki; Richard S Bockman; Benjamin S Glicksberg; Girish N Nadkarni; Deepak Vashishth
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

3.  Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Combining 177 Randomized Controlled Trials With a Median Follow-Up of 26 weeks.

Authors:  Sanbao Chai; Fengqi Liu; Zhirong Yang; Shuqing Yu; Zuoxiang Liu; Qingqing Yang; Feng Sun
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

4.  Challenges and Strategies for Inpatient Diabetes Management in Older Adults.

Authors:  Aidar R Gosmanov; Carlos E Mendez; Guillermo E Umpierrez
Journal:  Diabetes Spectr       Date:  2020-08

Review 5.  Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies.

Authors:  K Hidayat; Q-L Fang; B-M Shi; L-Q Qin
Journal:  Osteoporos Int       Date:  2021-04-16       Impact factor: 4.507

6.  High Glucose Downregulates Connexin 43 Expression and Its Gap Junction and Hemichannel Function in Osteocyte-like MLO-Y4 Cells Through Activation of the p38MAPK/ERK Signal Pathway.

Authors:  Lei Yang; Guangping Zhou; Mingyang Li; Yan Li; Liqing Yang; Qin Fu; Ye Tian
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-26       Impact factor: 3.168

Review 7.  Impact of Diabetes Mellitus on Bone Health.

Authors:  Cliodhna E Murray; Cynthia M Coleman
Journal:  Int J Mol Sci       Date:  2019-09-30       Impact factor: 5.923

8.  Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus.

Authors:  Sabaa Joad; Elliot Ballato; Fnu Deepika; Giulia Gregori; Alcibiades Leonardo Fleires-Gutierrez; Georgia Colleluori; Lina Aguirre; Rui Chen; Vittoria Russo; Virginia Carolina Fuenmayor Lopez; Clifford Qualls; Dennis T Villareal; Reina Armamento-Villareal
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-28       Impact factor: 5.555

Review 9.  Insulin Signaling in Bone Marrow Adipocytes.

Authors:  Michaela Tencerova; Meshail Okla; Moustapha Kassem
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

10.  Risk Factors for Incident Fracture in Older Adults With Type 2 Diabetes: The Framingham Heart Study.

Authors:  Alyssa B Dufour; Douglas P Kiel; Setareh A Williams; Richard J Weiss; Elizabeth J Samelson
Journal:  Diabetes Care       Date:  2021-05-17       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.